prolaio eVO2peak Module (Version 1.0)
510(k) K252204
prolaio eVO2peak Module (Version 1.0) is a medical device (FDA Class II; FDA product code PPW, Adjunctive Cardiovascular Status Indicator) made by Prolaio, Inc., cleared under FDA 510(k) K252204 on 16 Dec 2025, active as of 11 Oct 2026.
Active
510(k)
Valid until
No expiry
FDA recalls
None found
Documents
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK252204 | Date16 Dec 2025 | StatusActive |
Official records
- FDA 510(k) database K252204
From the FDA record
- Received by the FDA
- 14 Jul 2025
- FDA decision
- 16 Dec 2025 (Substantially Equivalent)
- FDA review time
- 155 days from receipt to decision
- Public document
- 510(k) summary on file with the FDA
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA product code
- PPW
- Device class
- Class II
- Regulation
- 21 CFR Part 870.2200
- Advisory committee
- Cardiovascular
- FDA decision
- SESE Substantially Equivalent
Devices cleared under K252204
Devices that FDA's GUDID lists as cleared or approved under this submission number. One submission usually covers a whole product family, so the sizes and models are listed here once.
| UDI-DI | Size and differences | |||
|---|---|---|---|---|
| prolaio eVO2peak Module 1.0 | 1.0 | 00850071330144 | — | On the market |
Similar devices
Other devices filed under FDA product code PPW (Adjunctive Cardiovascular Status Indicator).